03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Antizolid : | |
Type | Medicine Non Marketed |
Originator | Zyvox Injectable |
Agent | PharmaLab |
Distributor | PharmaLab |
Laboratory | Cooper Pharmaceuticals |
Responsible Party | Cooper SA Pharmaceuticals |
Origin | Greece |
Manufacturer | Cooper SA Pharmaceuticals |
Manufacturing Type | G |
Origin | Greece |
ATC | J01XX08 |
Antizolid :
Antizolid :
Antizolid :
Antizolid :
Antizolid :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal distension | Uncommon |
Abdominal pain | Common |
Alopecia | Not known |
ALT increased | Common |
Amylase increased | Common |
Anaemia | Common |
Anaphylaxis | Not known |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Not known |
Antibiotic associated colitis | Rare |
Arrhythmia | Uncommon |
AST increased | Common |
Bilirubin total increased | Uncommon |
Blood albumin decreased | Common |
Blood alkaline phosphatase increased | Common |
Blood bicarbonate decreased | Common |
Blood bicarbonate increased | Common |
Blood calcium decreased | Common |
Blood calcium increased | Uncommon |
Blood chloride decreased | Uncommon |
Blood chloride increased | Uncommon |
Blood creatinine increased | Uncommon |
Blood potassium decreased | Common |
Blood potassium increased | Common |
Blood sodium decreased | Common |
Blood sodium increased | Uncommon |
Blood urea nitrogen (BUN) increased | Common |
Bone marrow depression | Not known |
Candidiasis (Candida infection) | Common |
Cephalea | Common |
Chills | Uncommon |
Color changes of teeth | Rare |
Color vision change | Not known |
Constipation | Common |
Convulsion | Uncommon |
Creatine phosphokinase increased | Common |
Dermatitis | Uncommon |
Diaphoresis | Uncommon |
Diarrhoea (Diarrhea) | Common |
Dry mouth (Xerostomia) | Uncommon |
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Common |
Dyspepsia | Common |
Eosinophil count increased | Common |
Eosinophilia | Uncommon |
Excessive thirst | Uncommon |
Fatigue | Uncommon |
Fever | Common |
Fungal infection | Common |
Gastritis | Uncommon |
Glossitis | Uncommon |
Haematocrit decreased | Common |
Haemoglobin decreased | Common |
Hypertension | Common |
Hypoesthesia | Uncommon |
Hyponatraemia (Hyponatremia) | Uncommon |
Injection site pain | Uncommon |
Insomnia | Common |
Lactic acidosis | Not known |
LDH elevated | Common |
Leucopenia (Leukopenia) | Uncommon |
Leukocyte count decreased (White blood cell count decreased) | Common |
Lipase increased | Common |
Liver function test abnormal | Common |
Loose stools (Soft stools) | Uncommon |
Lyell Syndrome (Toxic epidermal necrolysis) | Not known |
Nausea | Common |
Neuropathy peripheral | Not known |
Neutropenia | Uncommon |
Neutrophil count decreased | Uncommon |
Neutrophil count increased | Common |
Optic neuritis | Not known |
Optic neuropathy | Not known |
Oral candidiasis | Common |
Pain | Common |
Pancreatitis | Uncommon |
Pancytopenia | Rare |
Paraesthesia (paresthesia) | Uncommon |
Phlebitis | Uncommon |
Platelet count increased | Common |
Polyuria | Uncommon |
Postprandial hyperglycemia | Common |
Postprandial hypoglycemia | Uncommon |
Protein total decreased | Common |
Pruritus | Common |
Pseudomembranous colitis | Rare |
Red blood cell count decreased | Common |
Renal insufficiency | Uncommon |
Reticulocyte count increased | Uncommon |
Serotonin syndrome | Not known |
Sideroblastic anaemia | Not known |
Skin rash | Common |
Stevens-Johnson syndrome | Not known |
Stomatitis | Uncommon |
Tachycardia | Uncommon |
Taste metallic | Common |
Thrombocytopenia (Thrombopenia) | Uncommon |
Thrombophlebitis | Uncommon |
Tinnitus | Uncommon |
Tongue discolouration | Uncommon |
Transient ischaemic attack | Uncommon |
Urticaria | Uncommon |
Vaginal candidiasis | Common |
Vaginitis | Uncommon |
Vertigo | Common |
Vision blurred | Uncommon |
Vision loss | Not known |
Visual acuity reduced | Not known |
Visual field defect | Rare |
Vomiting | Common |
White blood cell count increased | Common |
Antizolid :
NB : Products With Same Indication |
Different Units By MoH Code
Antizolid MoH 10475 :
Form | Solution for infusion |
Packaging | Plastic Bottle |
Package Size | 1x300ml |
Strength | 600mg |
Storage Condition | <25°C protect from light |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 19718/1 |
Submission date | 06/02/2018 |
Registration Year | 13/02/2019 |
Pending Year | 04/12/2018 |
Pending Reason | Incomplete file |
Archived Date | 03/05/2023 |
Price Comparison
● Country: | Greece | |
● Package Size: | 1 | |
● Public Price: | 19.12 EUR | ( 1,852,269.12 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 19,12 EUR | ( 1,840,644.00 LBP ) |
● Exfactory Price: | 13.23 EUR | |
● Pharmacy Price: | 13.88 EUR | ( 1344638.88 LBP ) |
● Reference: | National Organization for Medicines | |
● Pricing Date: | 20/08/2020 | |
● Type: | Medicine Authorised |
You have to register to view this info
Drop File